Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/08/2025
Asahi Shimbun: Defense ministers of Japan and South Korea will hold a meeting on September 8th.
Latest
1 m ago
The central parity rate of RMB against USD is reported at 7.1321.
1 m ago
Yanjinpuzi: It is expected that the konjac category will continue to see high growth in the next 3 to 5 years.
2 m ago
According to AI Express of Every Economy, on August 21, Great Wall Guorui Securities issued a research report giving a buy rating to Huadong Medicine (000963.SZ). The rating reasons include: 1) steady revenue growth, driven by the pharmaceutical industry with outstanding performance; 2) innovative product business revenue exceeding 1 billion yuan, entering a high-growth channel; 3) deep cultivation in three major treatment areas, with breakthroughs in the research and development pipeline of innovative drugs exceeding 80 items; 4) overall sales trend of industrial microorganisms sector continuing to improve; 5) medical beauty business under temporary pressure, showing a trend of improvement on a month-on-month basis. (Daily Economic News)
3 m ago
Yicai AI Fast News, on August 22nd, Cinda Securities issued a research report giving an A rating to Chengguang Stock (605183.SH). The rating reasons mainly include: 1) stable production and sales, with a record high sales volume in a single quarter; 2) relatively stable core operating indicators, not afraid of raw material fluctuations; 3) increased penetration rate of new energy vehicles, driving demand for green tires. (Daily Economic News)
4 m ago
Wu Xi Life (08148.HK) suspended trading from August 22nd.
See all latest
